Emily Schultz
Impact in
- Biotechnology top 10%
- Enzyme Production and Characterization
-
- Genomics and Phylogenetic Studies
- RNA and protein synthesis mechanisms
Papers in
-
- Advanced Breast Cancer Therapies 5
- Cancer-related cognitive impairment studies 2
- Oncology 5
- Cancer-related Molecular Pathways 2
- HER2/EGFR in Cancer Research 2
- Co-authors
- Shmuel Pietrokovski (1 shared paper)Timothy M. Rose (1 shared paper)C. Michael McCallum (1 shared paper)Steven Henikoff (1 shared paper)Erik S. Knudsen (6 shared papers)Ellis Levine (4 shared papers)Tracey L. O’Connor (4 shared papers)Agnieszka K. Witkiewicz (6 shared papers)
- Journals
- npj Breast Cancer (2 papers)Cancers (1 paper)Journal of Clinical Oncology (1 paper)Familial Cancer (1 paper)npj Precision Oncology (1 paper)
- Partner nations
- United StatesSouth AfricaCanada
In The Last Decade
Emily Schultz
7 papers receiving 637 citations
Emily Schultz's Hit Papers
Peers
Comparison fields: 5 of 87
- Biotechnology 50
- Molecular Biology 349
- Plant Science 165
- Aging 7
- Ecology 79
Countries citing papers authored by Emily Schultz
This map shows the geographic impact of Emily Schultz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily Schultz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily Schultz more than expected).
Fields of papers citing papers by Emily Schultz
This network shows the impact of papers produced by Emily Schultz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily Schultz. The network helps show where Emily Schultz may publish in the future.
Co-authors
The 25 scholars most cited alongside Emily Schultz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Consensus-degenerate hybrid oligonucleotide primers for amplification of distantly related sequences Hit paper breakdown → | 1998 | 605 |
| 2 | 2022 | 20 | |
| 3 | 2023 | 16 | |
| 4 | 2021 | 8 | |
| 5 | 2022 | 5 | |
| 6 | 2024 | 2 | |
| 7 | 2025 | 1 | |
| 8 | 2025 | 0 | |
| 9 | 2025 | 0 | |
| 10 | 2021 | 0 |
About Emily Schultz
Emily Schultz is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Cancer Research, Molecular Biology and Pathology and Forensic Medicine, having authored 10 papers that have together received 657 indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (5 papers), Breast Cancer Treatment Studies (4 papers), Cancer-related Molecular Pathways (2 papers), HER2/EGFR in Cancer Research (2 papers), Cancer-related cognitive impairment studies (2 papers), Genetic Associations and Epidemiology (1 paper), Genetic factors in colorectal cancer (1 paper) and RNA and protein synthesis mechanisms (1 paper). The work is most often cited by research in Biotechnology (50 citations), Molecular Biology (349 citations), Plant Science (165 citations), Aging (7 citations) and Ecology (79 citations). Emily Schultz has collaborated with scholars based in United States, South Africa and Canada. Frequent co-authors include Shmuel Pietrokovski, Timothy M. Rose, C. Michael McCallum, Steven Henikoff, Erik S. Knudsen, Ellis Levine, Tracey L. O’Connor, Agnieszka K. Witkiewicz, Kristopher Attwood and Stephen B. Edge. Their work appears in journals such as npj Breast Cancer, Cancers, Journal of Clinical Oncology, Familial Cancer and npj Precision Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.